| Stage | DGX | % of rev | VCYT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.1B | 100.00% | $152M | 100.00% | DGX ×20.41 |
| Gross profit | $1.0B | 33.65% | $107M | 70.58% | VCYT +36.9pp |
| Operating income | $479M | 15.47% | $17M | 10.92% | DGX +4.5pp |
| Pre-tax income | $416M | 13.43% | $21M | 13.92% | VCYT +0.5pp |
| Net income | $326M | 10.53% | $32M | 20.76% | VCYT +10.2pp |
| Stage | DGX | VCYT | Gap · A − B |
|---|---|---|---|
| Revenue | $3.1B100.00% | $152M100.00% | DGX ×20.41 |
| Gross profit | 33.65%$1.0B | 70.58%$107M | VCYT +36.9pp |
| Operating income | 15.47%$479M | 10.92%$17M | DGX +4.5pp |
| Pre-tax income | 13.43%$416M | 13.92%$21M | VCYT +0.5pp |
| Net income |
| 10.53%$326M |
| 20.76%$32M |
| VCYT +10.2pp |
No shared counterparties.